SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe